| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Xu Zhenyu serves as a Chief Scientific Officer at SOPH. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $5.0M at current prices.
The biggest single holding is SOPH (~$5.0M) as Chief Scientific Officer. The recent filings there lean toward selling, a net 36,120 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | SOPH Sophia Genetics SA | Chief Scientific Officer | Sale+OE | 20,000 | $7.25 | $144,923.80 | -1.1% | - | - | |
| Jul 13, 2026 | SOPH Sophia Genetics SA | Chief Scientific Officer | Sell | 4,000 | $5.70 | $22,819.20 | -0.7% | - | - | |
| Jun 15, 2026 | SOPH Sophia Genetics SA | Chief Scientific Officer | Sell | 4,000 | $5.01 | $20,056.40 | -0.6% | - | - | |
| Apr 13, 2026 | SOPH Sophia Genetics SA | Chief Scientific Officer | Sell | 8,120 | $4.73 | $38,374.02 | -0.4% | +16.5% | - |